Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
440 pending office actions • 263 clients • 367 examiners • 158 art units • 0 of 440 (0%) have an AI response strategy ready
COOLEY LLP operates in Biotechnology & Pharmaceuticals and shows a substantial active prosecution docket, with 440 pending office actions. Its career record contains 22165 applications, providing a broad historical base for evaluating prosecution activity. The scale of the record suggests that docket management, portfolio prioritization, and consistent response procedures are central operational considerations.
The resolved allowance rate is 78.25%, while the average is 3.53 office actions per allowance. These figures indicate that resolved matters often require multiple examination exchanges before allowance, and that outcomes are not uniform across the full historical portfolio. Practitioners may therefore find value in reviewing matter-specific prosecution histories rather than relying only on the aggregate profile.
Based on the USPTO statutory response window for each pending office action. 111 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 111 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 10 (2%) |
| §101 + other | 39 (9%) |
| §103 only | 89 (20%) |
| §102 only | 17 (4%) |
| §112 only | 37 (8%) |
| Double-patenting only | 13 (3%) |
| Double-patenting + other | 78 (18%) |
| Multi-statute (no §101) | 150 (34%) |
| No statute on record | 7 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOERNER, PAUL ELLSWORTH | 3 | 50.6% | +62.3% |
| HAGHIGHATIAN, MINA | 3 | 46.0% | +39.4% |
| COLEMAN, BRENDA LIBBY | 3 | 74.8% | +15.7% |
| BARSKY, JARED | 3 | 50.3% | +22.8% |
| TU, AURELIE H | 3 | 56.3% | +60.7% |
| HEASLEY, MEGHAN CHRISTINE | 3 | 74.5% | +36.3% |
| RODRIGUEZ, RAYNA B | 3 | 33.6% | +19.2% |
| LIU, SUE XU | 3 | 20.9% | +18.6% |
| ALLEN, MICHAEL D | 3 | 31.9% | +48.8% |
| SIMMONS, CHRIS E | 3 | 34.2% | +19.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17944127 | INTRA-AORTIC BALLOON PUMP ASSEMBLY | GHAND, JENNIFER LEIGH-STEWAR | 119d overdue |
| 18021323 | LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY | HOPKINS, SAMANTHA LAKE | 110d overdue |
| 17491079 | SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE CARDIAC MONITORING | XU, JUSTIN | 100d overdue |
| 17019042 | SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS | DELLA, JAYMI E | 100d overdue |
| 19175765 | BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING | PATEL, OM | 91d overdue |
| 18407010 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | TU, AURELIE H | 85d overdue |
| 17723112 | CLEAN SCREEN CONTACTLESS ANALYTE DETECTION TEST | GLOVER, NELSON ALEXANDER | 84d overdue |
| 17203464 | CONNECTION QUALITY ASSESSMENT FOR EEG ELECTRODE ARRAYS | PORTER, JR, GARY A | 81d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18407010 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | TU, AURELIE H | 85d overdue |
| 17083078 | SYSTEMS AND METHODS FOR PROCESSING SONIFIED BRAIN SIGNALS | TU, AURELIE H | 79d overdue |
| 18824121 | TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA | BARSKY, JARED | 49d overdue |
| 18182030 | PROTEASE BIOSENSORS AND METHODS OF VIRUS DETECTION | ALLEN, MICHAEL D | 46d overdue |
| 17914308 | BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS | HAGHIGHATIAN, MINA | 31d overdue |
| 18581000 | NOVEL COMPOUNDS AND USES THEREOF | COLEMAN, BRENDA LIBBY | 5d |
| 18138375 | SUBCUTANEOUS ADMINISTRATION OF AN ASBT INHIBITOR | BARSKY, JARED | 33d |
| 18188716 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | SIMMONS, CHRIS E | 42d |
| Art Unit | Apps |
|---|---|
| 3791 | 23 |
| 1628 | 13 |
| 3794 | 12 |
| 3771 | 12 |
| 3796 | 10 |
| 1626 | 10 |
| 1627 | 10 |
| 1622 | 10 |
| 1643 | 8 |
| 1624 | 8 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19551197 | APPARATUS AND METHOD FOR SEPTAL PENETRATION | Protaryx Medical Inc. | FLANAGAN, BEVERLY MEINDL | 3794 | §103 | Non-Final OA | — | Pending | Feb 26, 2026 |
| 19445099 | MULTI-SENSOR PATCH AND SIGNAL ANALYZER THAT ENABLE SAFE CARDIAC ABLATION | Field Medical, Inc. | VAHDAT, KHADIJEH A | 3794 | §103§112 | Final Rejection | — | Pending | Jan 09, 2026 |
| 19444133 | TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODES | Field Medical, Inc. | OUYANG, BO | 3794 | §103 | Final Rejection | — | Pending | Jan 08, 2026 |
| 19431012 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | Empathbio, Inc. | MOU, LIYUAN | 1628 | §103§112DP | Final Rejection | — | Pending | Dec 23, 2025 |
| 19429313 | SYSTEMS, DEVICES, AND METHODS FOR REDUCING HEART VALVE REGURGITATION | Nyra Medical, Inc. | MANNAN, MIKAIL A | 3774 | §102§103§112Other | Non-Final OA | — | Pending | Dec 22, 2025 |
| 19420125 | NATUREMOUNT SOLAR ARRAYS | 1St Avenue Nova, LLC | SUN, MICHAEL Y | 1728 | §102§103§112 | Non-Final OA | — | Pending | Dec 15, 2025 |
| 19413886 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO THE EYE | Astellas US LLC | SHIN, DANA H | 1635 | §102§112DP | Non-Final OA | — | Pending | Dec 09, 2025 |
| 19409031 | EPIGENETIC EDITING TOOL FOR TARGETING HEPATITIS B VIRUS GENE | Epigenic Therapeutics Pte. Ltd. | SHIN, DANA H | 1635 | §112Other | Final Rejection | — | Pending | Dec 04, 2025 |
| 19399418 | SYSTEMS, DEVICES, AND METHODS FOR CONTROLLING ACTUATION OF TISSUE RESECTION DEVICES | Prana Thoracic, Inc. | RHODES, NORA W | 3794 | §103 | Non-Final OA | — | Pending | Nov 24, 2025 |
| 19397849 | ABLATION DEVICES, SYSTEMS, AND METHODS | Field Medical, Inc. | DELLA, JAYMI E | 3794 | §103 | Non-Final OA | — | Pending | Nov 21, 2025 |
| 19393433 | MINIMALLY INVASIVE NASAL TURBINATE SURGERY | Spirair, Inc. | HOLWERDA, KATHLEEN SONNETT | 3771 | §102§103 | Final Rejection | — | Pending | Nov 18, 2025 |
| 19392021 | COMPOSITIONS AND METHODS FOR TREATING GENETIC DISORDERS | Fundación Para La Investigación Biomédica Del Hospital Infantil Universitario Niño Jesús | POPA, ILEANA | 1633 | §103 | Final Rejection | — | Pending | Nov 17, 2025 |
| 19383352 | METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE | Therakos Development Limited | HAMA, JOANNE | 1647 | §103DP | Non-Final OA | — | Pending | Nov 07, 2025 |
| 19374441 | METHODS AND SYSTEMS FOR FACILITATING OXYGEN-ENRICHED PARTIAL OXIDATION REACTIONS TO CONVERT HYDROCARBONS INTO CARBON MONOXIDE AND HYDROGEN | Emvolon, Inc. | ANTHONY, JOSEPH DAVID | 1764 | §103§112 | Non-Final OA | — | Pending | Oct 30, 2025 |
| 19320650 | ELECTROLYTE INCLUDING ELECTROLYTE SOLVENT, FLUOROETHER, AND BIS(FLUOROSULFONYL) SALT, AND LITHIUM METAL ELECTROCHEMICAL CELLS INCLUDING THE SAME | 24M Technologies, Inc. | CULLEN, SEAN P | 1725 | §102 | Final Rejection | 60d overdue | Pending | Sep 05, 2025 |
| 19305298 | APPARATUS AND METHOD FOR MEASURING AND APPLYING HIGH VOLTAGE THROUGH A MATRIX OF WIRES AND CONDUCTIVE ELEMENTS | Cardionxt, Inc. | RHODES, NORA W | 3794 | §102§103 | Non-Final OA | 18d overdue | Pending | Aug 20, 2025 |
| 19300138 | SYSTEMS AND METHODS FOR DELIVERY OF A SUBSTERNAL LEAD OF AN IMPLANTABLE DEVICE | North American EP Technology LLC | LAUER, CHRISTINA C | 3771 | §103 | Final Rejection | — | Pending | Aug 14, 2025 |
| 19300364 | SURGICAL ROBOTICS SYSTEMS AND DEVICES HAVING MODIFIED SPEED CONTROL NEAR WORKSPACE BOUNDARIES AND SURFACES, AND METHODS THEREOF | Distalmotion SA | MANCHO, RONNIE M | 3657 | §102 | Non-Final OA | — | Pending | Aug 14, 2025 |
| 19300150 | SYSTEMS, DEVICES, AND METHODS FOR HEALTH MONITORING VIA IMPLANTABLE DEVICES IN THE ANTERIOR MEDIASTINUM | North American EP Technology LLC | LOPEZ, SEVERO ANTON P | 3791 | §101§103DP | Final Rejection | — | Pending | Aug 14, 2025 |
| 19297926 | MYOCARDIAL IMPLANT LOAD SHARING DEVICE AND METHODS TO PROMOTE LV FUNCTION | Ancora Heart, Inc. | SCHERBEL, TODD J | §102 | Non-Final OA | — | Pending | Aug 12, 2025 | |
| 19290146 | MICRONEEDLE ARRAY SYSTEMS AND DEVICES, AND METHODS ASSOCIATED WITH MANUFACTURING AND USE | Panther Life Sciences Corporation | EPPERT, LUCY CLARE | 3791 | §103 | Final Rejection | 12d | Pending | Aug 04, 2025 |
| 19285497 | CIRCUITS AND METHODS TO HARVEST ENERGY FROM TRANSIENT ON-CHIP DATA | Metis Microsystems, LLC | LAM, TUAN THIEU | 2836 | §101 | Non-Final OA | — | Pending | Jul 30, 2025 |
| 19275299 | IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF HYDROGEN PEROXIDE | Anodyne Chemistries, Inc. | SAIDHA, TEKCHAND | 1652 | §102§112DP | Final Rejection | 10d overdue | Pending | Jul 21, 2025 |
| 19243836 | SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF | Argenx BV | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | 28d | Pending | Jun 20, 2025 |
| 19244861 | HEADSET FOR TRANSCRANIAL DIRECT-CURRENT STIMULATION, TDCS, AND A SYSTEM COMPRISING THE HEADSET | Flow Neuroscience AB | LEVICKY, WILLIAM J | 3796 | §102§103Other | Non-Final OA | — | Pending | Jun 20, 2025 |
| 19242555 | METHODS AND APPARATUS FOR MACHINE LEARNING BASED MALWARE DETECTION | Invincea, Inc. | HOFFMAN, BRANDON S | 2433 | §102Other | Non-Final OA | — | Pending | Jun 18, 2025 |
| 19234140 | DEVICES, SYSTEMS, AND METHODS FOR MANIPULATING NASAL TISSUES | Spirair, Inc. | LOUIS, RICHARD G | 3771 | §103Other | Non-Final OA | — | Pending | Jun 10, 2025 |
| 19228396 | SYSTEMS, DEVICES AND METHODS FOR HEALTH MONITORING AND IDENTIFICATION OF USERS | Casana Care, Inc. | BARR, MARY EVANGELINE | 3683 | §102§103 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19213905 | APPARATUSES FOR PULSED ELECTRIC FIELD ABLATION THERAPY INCLUDING EXPANDABLE ELECTRODES, AND SYSTEMS AND METHODS THEREOF | Alpfa Medical, Inc. | HUPCZEY, JR, RONALD JAMES | 3794 | §102§103 | Final Rejection | — | Pending | May 20, 2025 |
| 19204207 | WIRELESS INITIATION DEVICE | Orica International Pte. Ltd. | EGOAVIL, GUILLERMO J | 2847 | §112 | Non-Final OA | — | Pending | May 09, 2025 |
| 19196106 | ANTIGEN VARIANT OF VARICELLA ZOSTER VIRUS AND USE THEREOF | Mogam Institute For Biomedical Research | DRISCOLL, LORA E BARNHART | 3991 | §103§112DP | Non-Final OA | — | Pending | May 01, 2025 |
| 19193799 | DEVICES AND METHODS FOR TISSUE REMOVAL AND WOUND CLOSURE | Osheru, Inc. | LABRANCHE, BROOKE N | 3771 | §102§103 | Non-Final OA | — | Pending | Apr 29, 2025 |
| 19191923 | TRANSCATHETER DELIVERABLE PROSTHETIC HEART VALVES AND METHODS OF DELIVERY | VDyne, Inc. | YABUT, DIANE D | 3771 | §102§103DP | Non-Final OA | — | Pending | Apr 28, 2025 |
| 19123383 | Methods for Suppression of Gene Silencing in Plants | Biodrive, Inc. | KRUSE, DAVID H | 1663 | §102§103§112 | Non-Final OA | — | Pending | Apr 22, 2025 |
| 19181114 | SYSTEM AND METHOD FOR GENERATING A MULTI-COMPONENT SIGNAL INCLUDING A MODULATED SIGNAL AND AN AUXILIARY SIGNAL | Terawave, Inc. | KASSA, ZEWDU A | 2635 | §103 | Non-Final OA | — | Pending | Apr 16, 2025 |
| 19181139 | METHOD FOR EMBEDDING MESSAGE WAVEFORMS WITHIN CONVENTIONALLY MODULATED SIGNALS | Terawave, Inc. | SALTARELLI, DOMINIC D | 2421 | §102§103Other | Non-Final OA | — | Pending | Apr 16, 2025 |
| 19178636 | METHODS AND APPARATUS FOR ESTIMATING DEPTH INFORMATION FROM THERMAL IMAGES | Rivet Industries, Inc. | SUMMERS, GEOFFREY E | 2669 | §112 | Final Rejection | 1d overdue | Pending | Apr 14, 2025 |
| 19177229 | APPARATUSES, SYSTEMS, AND METHODS FOR PROCESSING OF THREE DIMENSIONAL OPTICAL MICROSCOPY IMAGE DATA | Alpenglow Biosciences, Inc. | RIDER, JUSTIN W | 2486 | §103 | Non-Final OA | — | Pending | Apr 11, 2025 |
| 19175765 | BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING | Magnolia Medical Technologies, Inc. | PATEL, OM | 3791 | §103§112 | Non-Final OA | 91d overdue | Pending | Apr 10, 2025 |
| 19171122 | SYSTEM AND METHOD FOR AUTOMATIC ANALYSIS OF TEXTS IN PSYCHOTHERAPY, COUNSELING, AND OTHER MENTAL HEALTH MANAGEMENT ACTIVITIES | Mind Medicine, Inc. | LANE, DANIEL E | 3715 | §101§102§112 | Non-Final OA | — | Pending | Apr 04, 2025 |
| 19098805 | SYSTEMS AND METHODS FOR SEIZURE DETECTION | Ceribell, Inc. | MCCORMACK, ERIN KATHLEEN | 3791 | §101§103§112 | Non-Final OA | — | Pending | Apr 02, 2025 |
| 19098339 | METHOD FOR COMMUNICATION OVER TIME-BASED CHANNELS | Terawave, Inc. | PEREZ, JAMES M | 2635 | §112 | Non-Final OA | — | Pending | Apr 02, 2025 |
| 19088669 | APPARATUS AND METHOD FOR A NEURAL INTERFACE UTILIZING SENSORY COMMUNICATION TO AFFECT A BROAD SPECTRUM OF PHYSIOLOGIC ACTIVITY IN THE HUMAN BODY | Synapcis Inc. | TRAN, JENNY NGAN | 2615 | §101§103§112 | Non-Final OA | — | Pending | Mar 24, 2025 |
| 19084221 | SYSTEMS AND METHODS FOR ANALYZING, INTERPRETING, AND ACTING ON CONTINUOUS GLUCOSE MONITORING DATA | Welldoc, Inc. | BLOCH, MICHAEL RYAN | 3791 | DP | Non-Final OA | — | Pending | Mar 19, 2025 |
| 19080483 | SYSTEMS AND METHODS FOR DETECTING FOODBORNE PATHOGENS USING SPECTRAL ANALYSIS | Hyperspectral Corp. | KIDWELL, KAITLYN ELIZABETH | 2877 | §101§103 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 19076444 | APPARATUS AND METHOD FOR CONDUCTING ENDPOINT-NETWORK-MONITORING | Huntress Labs Incorporated | GRACIA, GARY S | 2499 | §103 | Non-Final OA | — | Pending | Mar 11, 2025 |
| 19069118 | APPARATUS AND METHOD FOR TREATING NEUROLOGICAL DISORDERS | Newronika S.p.A. | ROANE, AARON F | 3792 | §101§102Other | Non-Final OA | — | Pending | Mar 03, 2025 |
| 19065984 | ONE-OPERATOR SURGICAL SYSTEM AND METHODS OF USE | Levita Magnetics International Corp. | GHIMIRE, SHANKAR RAJ | 3795 | §102§103 | Non-Final OA | — | Pending | Feb 27, 2025 |
| 19104558 | SYSTEM AND METHODS FOR PRODUCING FUNCTIONALIZED NATURAL FIBERS | Heartland Industries, Inc. | AHMED, SHEEBA | 1787 | §102§103 | Non-Final OA | — | Pending | Feb 18, 2025 |
| 19053798 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | Azora Therapeutics, Inc. | LEE, SIN J | 1613 | §103 | Non-Final OA | — | Pending | Feb 14, 2025 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.2% of resolved applications prosecuted by Cooley LLP were allowed, across 22,165 applications in USPTO records.
3.53 office actions per allowed application on average.
440 pending office actions as of October 2026, for 263 clients, before 367 examiners in 158 art units.
